Navigation Links
Textile Company PurThread Technologies Opens Headquarters in Durham, North Carolina and Hires New Senior Staff
Date:6/26/2012

DURHAM, N.C., June 26, 2012 /PRNewswire/ --  A new medical textile company has established its headquarters in Durham, North Carolina. PurThread Technologies, a development-stage biotech firm dedicated to using antimicrobial textile technology to help hospitals reduce the bioburden in the patient environment, chose Durham for its access to key textile and medical industry players.  The new PurThread headquarters also brings with it two new senior staff; Dr. Stanley D. Chamberlain as the new Chief Scientific Officer and Michael Weldon as the new Senior Director of Sales for the Northeast Region.  The company's founder and current Chief Scientific Officer, Stephen Foss will now serve as PurThread's Chief Technology Officer.

"Durham is a great place for us," said Bill O'Neill Vice President of Infection Control Applications at PurThread Technologies. "Here we are surrounded by the medical and textile industry ecosystem and closer to many current and potential partners. We are thrilled to call Durham home and look forward to supporting the economy here and throughout the Carolinas."

PurThread develops textiles, such as privacy curtains, linens and hospital garments that help to reduce the level of bioburden on hard-to-clean soft surfaces in healthcare environments, as well as in military and consumer applications. The textiles employ the antimicrobial effects of silver, copper and other elements in a proprietary Complex Element Compound to create a continuously active and soft textile. Studies have shown that reducing the level of bioburden within the patient environment can lead to a reduction in healthcare associated infections (HAIs). In the US, 100,000 people die each year from HAIs making them the fourth largest cause of mortality according to the Centers for Disease Control and Prevention (CDC).

PurThread Management Team Additions

Chief Scientific Officer
Stanley D. Chamberlain

Stanley D. Chamberlain, Ph.D. served most recently as Vice President of Chemistry at Inhibitex. Since early 2008, he was responsible for the R&D efforts of the anti-HCV compound INX-08189. Prior to Inhibitex, Chamberlain was Senior Group Manager in Medicinal Chemistry Oncology at Glaxo SmithKline in Research Triangle Park.  Additionally, Dr. Chamberlain was a Group Leader at Glaxo Wellcome and held Senior Scientist positions at Burroughs Wellcome.

Senior Director of Sales
Michael Weldon

Michael Weldon brings a rich 18-year history in healthcare sales to PurThread, as its new Senior Director of Sales. Before joining the company, he was Senior Director, Market Management at VHA New England, a group purchasing organization for hospitals. Prior to VHA, he was Senior Consultant at Andersen Consulting and Operations Manager at J.D. Cahill Company.

About PurThread Technologies, Inc.

PurThread Technologies, Inc., an emerging leader in antimicrobial textile technology research, is dedicated to developing continuously active soft surfaces that show a measureable difference in  reducing the bioburden in clinical patient environments. PurThread supports current healthcare infection prevention and hand hygiene efforts by providing an additional layer of protection between patients and the freshly washed hands of healthcare workers. PurThread products range from healthcare textiles, such as privacy curtains, sheets, scrubs, blankets, and lab coats, as well as a range of products for other markets such as the military, emergency first responders and performance athletic wear. For more information on PurThread Technologies, Inc., please visit www.PurThread.com.

Media Contact:

Technica Communications
Lisa Ann Pinkerton
408-806-9626
Lisaann@technicacommunications.com


'/>"/>
SOURCE PurThread Technologies
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. GeneTex Antibody Company to Launch New Line of Primary Antibodies for the Study of Spindle Assembly
2. Monsanto Declared Worst Company of 2011 by NaturalSociety
3. Fox Insurance Company Awarded $3.3 Million in Arbitration Against Former Pharmacy Benefit Manager
4. Oxford Finance Provides $15 Million Senior Secured Credit Facility to Private Equity Backed Healthcare Services Company
5. Leading Pharmaceutical Marketing Research and Consulting Company Introduces Intelligent Efficiency Program
6. Meaningful Use Stage Two: The Advisory Board Company Helps Hospitals Set Strategy
7. Aneesh Chopra to Serve as Senior Advisor to The Advisory Board Company
8. Regado Biosciences, Inc. to Present at the Cowen and Company 32nd Annual Health Care Conference in Boston, MA
9. Incline Therapeutics to Present at the Cowen and Company 32nd Annual Health Care Conference
10. Receptos to Present at the Cowen and Company 32nd Annual Health Care Conference
11. Nycomed, a Takeda Company, Launches OmnarisĀ® Nasal Spray in the UAE for the Treatment of Allergic Rhinitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 2016  Regular discussions on a range of subjects including ... two entities said Poloz. Speaking at a lecture ... , he pointed to the country,s inflation target, which is ... "In certain areas there ... common economic goals, why not sit down and address strategy ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Researchers at ... most commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings are the ... read it now. , Diagnostic biomarkers are signposts in the blood, lung fluid ...
(Date:6/23/2016)...   Boston Biomedical , an industry leader ... target cancer stemness pathways, announced that its lead ... Designation from the U.S. Food and Drug Administration ... gastroesophageal junction (GEJ) cancer. Napabucasin is an orally ... stemness pathways by targeting STAT3, and is currently ...
(Date:6/23/2016)... Houston Methodist Willowbrook Hospital has signed ... to serve as their official health care provider. ... will provide sponsorship support, athletic training services, and ... volunteers, athletes and families. "We are ... and to bring Houston Methodist quality services and ...
Breaking Biology Technology:
(Date:6/2/2016)... --  The Weather Company , an IBM Business (NYSE: ... in which consumers will be able to interact with IBM ... voice or text and receive relevant information about the product ... have long sought an advertising solution that can create a ... and valuable; and can scale across millions of interactions and ...
(Date:5/16/2016)... , May 16, 2016   EyeLock LLC , ... announced the opening of an IoT Center of Excellence ... and expand the development of embedded iris biometric applications. ... level of convenience and security with unmatched biometric accuracy, ... identity aside from DNA. EyeLock,s platform uses video technology ...
(Date:4/28/2016)... , April 28, 2016 First quarter 2016: ... up 966% compared with the first quarter of 2015 ... SEK 589.1 M (loss: 18.8) and the operating margin was 40% ... 0.32) Cash flow from operations was SEK 249.9 M ... revenue guidance is unchanged, SEK 7,000-8,500 M. The operating ...
Breaking Biology News(10 mins):